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ABSTRACT
The experimental investigation was performed to study the effects of methylene blue (MB)
on hemodynamic, biochemical, and tissue changes among rabbits undergoing liver
ischemia and reperfusion (IR). Twenty-four rabbits were randomized into 5 groups: 1,
SHAM, control; 2, MB infusion bolus (3 mg/kg); 3, IR, hepatic ischemia for 60 minutes
followed by 120 minutes of reperfusion; 4, MB-R, undergoing ischemia that had received
an MB bolus infusion (3 mg/kg) prior to reperfusion; 5, R-MB, undergoing ischemia and
MB bolus infusion after hemodynamic instability caused by reperfusion. The analysis
included continuous recording of vital signs. Blood samples were collected at 0, 60, and 180
minutes of IR to determine blood gases as well as biochemical markers of liver function,
nitric oxide, lipid peroxidation, and neutrophil activity. At the end of each experiment,
liver tissue samples were collected for histological evaluation of parenchymae markers.
Statistical analysis used two-way analysis of variance (ANOVA) tests with significance set
at P  .05. Vital signs significantly improved with MB infusion, irrespective of whether it
was applied before or after reperfusion. Blood gas data revealed different patterns among
the SHAM, MB, IR, MB-R, and R-MB groups, without statistical significance, except for
favorable lactate results in the R-MB group (P  .01), which displayed greater survival.
Biochemical tests did not show significant differences among the groups, whereas
histological analysis revealed favorable appearances for the MB-R and R-MB groups. The
MB effect lasted long after reperfusion, suggesting that improvement in the hemodynamic
parameters was not based on liver integrity, but rather was possibly related to endothelial
function.
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cPRIMARY graft dysfunction resulting from ischemia-reperfusion (IR) injury is still an important cause of
morbidity and mortality among patients undergoing liver
transplantation. Mortality can be higher when IR injury is
associated with systemic repercussions such as cardiocircu-
latory collapse, culminating in the so-called Ischemia and
Reperfusion Syndrome (IRS). The dye methylene blue
(MB) has been used as a vasopressor in sepsis and acute
liver failure. Sepsis and IRS share many hemodynamic and
biochemical similarities, including the patterns of increased
pro-inflammatory cytokines. Several modes of action have
been postulated for MB, depending on the clinical situa-
tion. MB acts not only nitric oxide (NO) blocker by
inhibiting guanylate cyclase (GC), but also as an inhibitor of
nitric oxide synthase (NOS).
Koelzow et al1 showed that MB attenuates the hemody-
amic changes caused by IRS following transplantation via
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ions corroborated Koelzow’s clinical experience. The pres-
nt work in rabbits sought to evaluate: (1) the effects of MB
n cardiovascular repercussions due to liver IR and its
emodynamic implications; (2) the effects of MB on
hanges in arterial blood gases and markers of acute
irculatory shock (differences in lactate and O2 extraction);
3) the NO biochemical products and liver function plasma
arkers in blood collected during various steps; (4) the
hanges in liver tissue products derived from NO, lipid
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3644 ROSIQUE, ROSIQUE, ROSIQUE ET ALperoxidation, and protein oxidation at the end of each
experiment; and (5) the histological changes in liver paren-
chyma in situations of IR.
MATERIALS AND METHODS
The experimental and animal procedures were approved by our
Institutional Animal Care Review Board. This investigation was
carried out according to the Guidelines for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85-23, revised 1996). Before the
experiments, the rabbits were housed under standard laboratory
conditions (12-hour light/dark cycle at 21°C), with free access to
water.
Characterization of Experimental Groups
Thirty white male New Zealand rabbits weighing between 2.5 and
3.5 kg were randomized into 5 groups: (1) SHAM controls; (2) MB
bolus (3 mg/kg); (3) IR, animals undergoing 60 minutes of hepatic
ischemia followed by 120 minutes of reperfusion; (4) MB-R,
animals undergoing schemia that received MB bolus (3 mg/kg)
prior to reperfusion; and (5) R-MB, animals subjected to ischemia
with MB infusion bolus after hemodynamic instability caused by
reperfusion.
Experimental Procedure
Anesthesia consisted of intramuscular xylazine (10 mg/kg) associ-
ated with ketamine (50 mg/kg) once in the hind legs. This associ-
ation was maintained during the experiment, repeating a third
bolus every 90 minutes for analgesia and sedation. The animals
received an intravenous infusion of 10 mL/kg/h sodium chloride
(0.9%) to compensate for insensible loss during the procedure.
They were maintained under spontaneous ventilation with have O2
catheter. After anesthesia, the right internal jugular vein and
common carotid artery were cannulated with polyethylene cathe-
ters. Samples of arterial and venous blood obtained at the begin-
ning of the experiment (time zero), the end of ischemia (60
minutes), and the end of reperfusion (180 minutes) were used to
measure blood gases, lactate, nitrite/nitrate, aspartate aminotrans-
ferase (AST), alanine aminotransferase (ALT), alkaline phospha-
tase (ALP), and lactic dehydrogenase (LDH). The surgical access
was performed by median infraumbilical minilaparotomy. Except
for the SHAM group, the hepatic artery of all the animals was
clamped at the hilum for 60 minutes. Thereafter the clamp was
removed for liver reperfusion. An MP 100 A system (Biopac
System, Inc., Santa Barbara, Calif, United States) was used to
monitor mean arterial pressure (MAP) and central venous pressure
(CVP) and to record the electrocardiogram (ECG). At the end of
the experiment, the animals were humanely killed by exsanguina-
tion and samples were taken from the liver parenchyma for
histological analysis, measurement of malondialdehyde (MDA)
and nitrite/nitrate.
Serum Enzymes
Blood samples were immediately centrifuged, and serum levels of
liver function markers were measured by specific methods. ALT
was determined using the kinetic method (ALT/GPT Liquiform
Ref. 108, Labtest Diagnostica SA, Lagoa Santa, MG, Brazil); AST
was also analyzed using the kinetic method (AST/GOT Liquiform
- Ref 109, Labtest Diagnostica SA, Lagoa Santa, MG, Brazil); ALPwas measured using the colorimetric method (Alkaline Phospha-
tase - Ref 40, Labtest Diagnostica SA, Lagoa Santa, MG, Brazil);
LDH was determined using the Pyruvate-Lactate UV method
(Liquiform - Ref 86 Labtest Diagnostica SA, Lagoa Santa, MG,
Brazil).
Blood Gases and Lactate
The arterial and venous blood gases as well as the lactate levels
were measured using a conventional blood gas Gem Premier 3000
instrument (Instrumentation Laboratory Co., Bedford, Mass,
United States) that had previously been calibrated using a cartridge-
type IQM 150 (GEM Premier, Instrumentation Laboratory Co.,
Bedford, Mass, United States).
Nitrite/Nitrate (NO)
The NO contents in deproteinized liver tissue homogenates and
plasma samples were measured using NO/Ozone chemilumines-
cence (Sievers 280 NO analyzer, GE Analytical Instruments,
Boulder, Col, United States).
Lipid Peroxidation Assay in the Liver
Tissue samples from ischemic and nonischemic livers were homog-
enized with ice-cold Ringer’s solution to determine of MDA levels,
using a commercial kit (Lipid Peroxidation Assay Kit, Calbiochem,
Merck & Co. Inc., Whitehouse Station, NJ, United States), with
readings of absorbance at 586 nm.
Histological Analysis
Liver tissue samples were placed in 10% paraformaldehyde for 24
hours fixation before paraffin embedding, and 5-m transverse
sectioning using a Reichert Jung microtome model 2040. Selections
were stained with hematoxylin and eosin (HE), Masson, Giemsa-
Wolbach modified method to differentiate leukocyte nuclei fol-
lowed by histological examination under a light microscope.
The histological study included evaluation of the hepatic paren-
chyma in all of the animals of each experimental group, taking the
following characteristics into account: (1) interstitial hemorrhage,
(2) parenchymal necrosis, (3) inflammatory reactions, and (4)
interstitial edema. Each of these features was classified as mild,
moderate, or severe.
The liver tissue stained with Giemsa was used for the neutrophil
count among 5 animals in each study group. We chose locations
with greater numbers of leukocytes: 2 fields near portal spaces and
2 in the liver lobe at 400 times magnification. The number of
neutrophils present in the vessels was counted by a cytopathologist,
blinded as to each rabbit’s group. We did not count leukocytes in
the process of diapedesis.
A Zeiss (Zeiss, Berhlim, Germany) plus was used for the
histological analysis and neutrophil count. The field images used
for measurement were recorded with a camera (Axio Cam Hrc)
attached to the microscope, and subsequently filed using the (Zeiss,
Berhlim, Germany).
Statistical Analysis
The values corresponding to blood gas results, as well as hemody-
namic and biochemical data are expressed as mean values with
standard deviations. Two-way analysis of variance (ANOVA) was
used for the statistical analysis, which was complemented with
Bonferroni tests for paired observations. One-way ANOVA and
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EFFECT OF METHYLENE BLUE 3645the Bonferroni post-test for multiple comparisons were used to
compare groups of data obtained from tissue analyses of NO,
MDA, and mean number of neutrophils. Calculations were accom-
plished using GraphPad Prism 4.0 (GraphPad Software Inc., San
Diego, Calif, United States). A level of P  .05 was accepted to be
indicative of statistical significance.
RESULTS
Hemodynamic Data, Mortality, and Time of Observation
MAP values for the SHAM and MB groups remained
virtually stable during the 3-hour observation, with only
slight reductions. All of the groups subjected to ischemia,
namely IR, MB-R, and R-MB, displayed an initial in-
crease in MAP, followed by a steady decrease during
ischemia (60 minutes). During reperfusion, there was a
sudden decrease in MAP among the group that did not
Fig 1. Survival curve (Kaplan-Meier analysis) of each group as
a function of time (min).eceive MB (IR), with death of 4 of the 6 animals within
he first 10 minutes. The group to which MB was
dministered prior to reperfusion (MB-R) showed no
udden decrease in MAP at the beginning of reperfusion.
heir blood pressure levels were greater than the IR
roup up to 60 minutes of reperfusion (P  .05); there
ere 3 deaths at 20, 40, and 95 minutes reperfusion,
espectively. In the R-MB group, the drug infusion
roduced an increase in MAP, yielding average levels
reater than those obtained for the IR (P  .01) or
B-R (P  .05) groups up to 55 minutes of reperfusion;
here were 2 deaths (65 and 100 minutes of reperfusion,
espectively; Fig 1 and Fig 2).
There was only a slight decrease in CVP during the
xperiment in the SHAM and MB groups. All the groups
nderwents steady CVP reduction during the 60 minutes of
schemia. During reperfusion, there was a sudden CVP
ecrease among the IR group. As for the MB-R and R-MB
roups, the CVP increased upon reperfusion followed by a
teady decrease after reperfusion. This difference was sig-
ificant (P  .05) in the first 20 (for the IR and MB-R
groups) and 60 minutes (for the R-MB group) of reperfu-
sion (P  .05; Fig 3).
Compared with the SHAM group, there were no differ-
ences in the heart rate (HR) during the whole period of
ischemia (60 minutes) among the IR, MB-R, and R-MB
groups. During reperfusion, there was an abrupt decrease in
HR in the IR group. In the case of the MB-R and R-MB
groups, there was a slight enhancement in HR with reper-
fusion, followed by a progressive decrease. The difference in
HR was significant (P  .05) in the first 15 (for the IR and
MB-R groups) and 50 (for the R-MB group) minutes of
reperfusion (Fig 4).
Fig 2. MAP values (mm Hg) as a
function of time (min). *In the
R-MB group, drug infusion
caused an increase in MAP and
furnished average MAP levels
higher than those obtained for the
IR (P  .01) and MB-R (P  .05).
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Intergroup analysis of ALP revealed no differences among
the groups. There was a significant increase in LDH among
the last samples obtained from the SHAM and MB groups
(P  .001) and the MB-R group (P  .05). The AST values
n the last samples collected from both MB-R and R-MB
roups were significantly higher compared with the SHAM
nd MB groups (P  .001 and P  .05, respectively),
without a significant difference compared with the IR
group. The ALT values measured in the last samples
Fig 3. Mean CVP values (mm
Hg) as a function of time (min).
*During reperfusion, there was a
sudden CVP decrease in the IR
group. As for the MB-R and
R-MB groups, CVP increased on
reperfusion, followed by a steady
decrease. This difference was
significant (P  .05) in the first 20
(for the IR and MB-R groups) and
60 minutes (for the R-MB group)
of reperfusion (P  .05).ollected from the MB-R and R-MB groups were signifi-
antly increased compared with SHAM animals (P  .001
nd P  .05, respectively), without a significant difference
ompared with the IR group (Table 1).
Plasma Nitrite/Nitrate (NO), Lactate, and Blood Oxygen
Saturation Arterial-Venous Difference in Oxygen Saturation
Compared with the IR group, the MB-R and R-MB groups
showed significant difference in lactate levels (P  .001),
esembling the curves obtained for the SHAM and MB
Fig 4. Mean HR values beats
per minute [bpm] as a function of
time (min). *The difference in HR
was significant (P  .05) in the
first 15 (for the IR and MB-R
groups) and 50 (for the R-MB
group) minutes of reperfusion.
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EFFECT OF METHYLENE BLUE 3647groups. There were no significant differences between the
MB-R and R-MB groups (P  .05; Fig 5A). Intergroup NO
statistical analysis revealed no difference. The MB group
presented values quite similar to those recorded for the
SHAM group, with no significant difference on comparison
with the other groups (P  .05; Fig 5B) The MB-R and
R-MB groups displayed significantly different in oxygen
Table 1. Liver
SAMPLE-1
AST ALT A
SHAM 42.83 57.33 2
B 24.60 75.40 4
R 35.66 57.00 7
B-R 33 43.5 20
-MB 29.83 48.50 25
Note: Blood samples were taken at the beginning of the experiment (time ze
Fig 5. (A) Mean lactate (mmol/L). *Compared with the IR group,
the MB-R and R-MB groups presented significant difference
concerning the lactate levels (P  .001), resembling the curves
btained for the SHAM and MB groups. (B) NO (moL) values
observed in the groups according to the time of sample collec-
tion. *In the intergroup analysis, there were no statistically
significant differences in terms of NO dosage. Note: Blood
samples were taken at the beginning of the experiment (time
zero), at the end of ischemia (60 min), and at the end oflreperfusion (180 min).saturation levels (P  .05) compared with the IR group,
esembling the curves obtained for the SHAM and MB
roups. There were no significant differences between the
B-R and R-MB groups (P  .05; Fig 6).
Liver Tissue Nitrite/Nitrate (NO) and MDA
In the intergroup analysis, there were no significant differ-
ences in terms of tissue NO dosage. It is noteworthy that the
curve obtained for the R-MB group was quite similar to that
of the SHAM group (P  .05; Fig 7A). There were no
significant differences among the groups with respect to
tissue MDA measurements (P  .05; Fig 7B).
Histological Analysis
The histological analyses performed on the SHAM and MB
groups were quite similar. The IR group revealed an
inflammatory pattern with areas of congestion edema, and
cellular necrosis (Fig 8A), as well as diffuse infiltrates with
1 animal showing a few hepatocytes containing cytoplasmic
vacuoles (Fig 8B).
The number of intravascular neutrophils was smaller
among the MB-R revealing less inflammatory reaction and
less perivascular leakage of blood vessels into the paren-
chyma (Fig 9A and 9B). The average number of neutrophils
was greater among the IR, R-MB, and MB-R compared
with the SHAM and MB groups (P  .0016; one- way
ANOVA test) SHAM IR (P .01); SHAMR-MB and
HAM  MB-R (P  .05); MB  IR (P  .01); MB 
-MB and MB  MB-R (P  .05; Bonferroni multiple
omparison post-test; Fig 9C and 9D).
DISCUSSION
Apart from the setting of sepsis,2–4 MB has been used as a
asopressor in acute liver failure (1–3 mg/kg).5,6 When the
MAP decreases, MB bolus causes it to increase by increas-
ing peripheral vascular resistance and, in some cases, by
enhancing the cardiac index. Sepsis syndrome and IRS
share biochemical and hemodynamic variables, including
higher levels of pro-inflammatory cytokines.7
There are few literature reports on the use of MB during
circulatory shock, more specifically when caused by liver
graft reperfusion. Koelzow et al successfully used MB in
humans.1 Since then, anesthesiologists who specialize in
m Enzymes
SAMPLE-2 SAMPLE-3
ALT AST ALT
54.83 30.66 53.16
121.60 40.80 63.40
75.50 586.75 272.50
113.83 960.50 211.50
94.50 1285.5 452.66
t the end of ischemia (60 min), and at the end of reperfusion (180 min).Seru
ST
9.16
4.60
6.66
8.16
4.83iver transplantation have described the use of MB to
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3648 ROSIQUE, ROSIQUE, ROSIQUE ET ALreverse situations of postoperative circulatory shock, de-
spite the vasopressor properties of this compound.8,9
The experimental model used herein employed continu-
ous registration of MAP, CVP, and HR values; biomarkers
were determined at previously defined moments, namely
baseline, end of ischemia, and end of the experiment. The
histological samples were only collected at the end of the
experiment. Male rabbits were used to avoid a possible
influence of the menstrual cycle. In addition to the SHAM
group, the investigated groups included animals undergoing
IR either treated prophylactically prior to reperfusion
(MB-R), as described by Koelzow et al,1 or following
reperfusion, according to Fischer et al.10 Subsequently,
nother SHAM group received MB but was not subjected
o IR, seeking to assess whether the therapeutic response to
B depended on the ischemic injury.
The anesthetic technique was based on studies that used
similar methodology in rabbits.11 Moreover, anesthesia
ith ketamine/xylazine used herein provided good analge-
ia and spontaneous breathing without relevant hemody-
amic repercussions. Supplementary oxygen was used; in-
alation proceeded via a low-flow catheter (2 L/min) to
revent hypoxia manifested by clinical cyanosis. However,
his maneuver invalidated the blood gas parameters be-
ause the absolute oxygen concentration could not be
ompared among animals, except for the relative concen-
ration between arterial and central venous oxygen.
Concerning the IR model adopted in this investigation, it
as necessary to establish a reasonable period of ischemia,
o that the IRS would be triggered without a high animal
ortality. Previous protocols have adopted 20,12 30,13 or 60
minutes of ischemia.11 Ischemic times shorter than 60
minutes were insufficient to trigger IRS in this pilot study,
Fig 6. Mean values of SpO2
(a–v) difference (%) observed in in
the groups according to the time
of sample collection. *Compared
with the IR group, the MB-R and
R-MB groups presented signifi-
cant difference concerning the
lactate levels (P  .001), resem-
ling the curves obtained for the
HAM and MB groups. Note:
lood samples were taken at the
eginning of the experiment (time
ero), at the end of ischemia (60
in), and at the end of reperfu-
ion (180 min).whereas longer ischemic times generated immediate circu- matory shock and death. For this reason, we selected 60
inutes of ischemia. We used survival time after the onset
f reperfusion as an indicator of MB effectiveness.
As for the reperfusion period, it is known that the
xpression of inducible NOS (iNOS) takes about 4–6 hours
o be detectable, but in clinical practice the onset and
erification of the effects IRS are almost immediate, allow-
ng us to conclude that the observation period for MB
ctivity could be shortened to 120 minutes.
Unfortunately, due to the size of the rabbits, a Swan-
anz catheter was not feasible, so it was not possible to
easure cardiac output, pulmonary capillary wedge pres-
ure, or peripheral vascular resistance. Therefore, the cri-
eria for cardiovascular collapse were based on MAP, CVP,
nd HR records. Plasma lactate levels and SpO2(a–v)
eterminations were performed to improve the sensitivity
f the diagnosis of circulatory shock. In the specific case of
actate levels, we were concerned that MB would interfere
ith the measurement; however, the device (Gem Premier
000) used herein employed an amperometric method,
hich was not susceptible to colorimetric interference.
The MB dose was injected as an endovenous bolus,
ccording to literature reports.4,14 Generally, IRS is related
o primary dysfunction of the tissue/organ subjected to
schemia. Therefore, in the present study we analyzed liver
unction to verify whether MB prevented IRS. Once MB
as proven to be effective, we examined whether it de-
ended on NO expression. A further question was whether
B action is systemic, or affect\ill\ liver parenchyma only,
r perceived systemically and in the liver. To address these
uestions, NO was measured in both liver tissue and plasma
nd indirect free radical activity (MDA) was also deter-
ined in the liver. At the end of the experiments, a
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irreversible.
Hemodynamic results confirmed the findings of Koelzow
et al.1 The MAP of control animals remained stable, with a
slight decrease in levels during the experimental period of
180 minutes. Animals belonging to the IR group underwent
a sudden decrease in MAP within the first 5 minutes of
reperfusion, with deaths of 4 of the 6 animals, thereby
demonstrating the severity of IRS in terms of mortality.
Two animals died among MB administrations (MB-R
group), but their deaths occurred at 20 and 40 minutes of
reperfusion. As for the group subjected to treatment with
MB (R-MB group), only 1 animal died at 60 minutes of
reperfusion. The CVP and HR profiles accompanied the
MAP events, with minor variations, thus confirming the
conclusions above.
Biochemical tests to assess liver function gave evidence of
significant increases in ALT and AST levels among all
groups, a finding that was consistent with the literature.15
The use of MB did not attenuate this increase. These results
support the conclusion that MB does not confer protection
to liver parenchyma with respect to the maintenance of
Fig 7. (A) Mean tissue NO (g/mg) and (B) tissue MDA (g/mg)
values observed in the groups. *In the intergroup analysis, there
were no statistically significant differences in terms of NO and
MDA dosage (P  .05).normal physiological conditions. mLiver NO production showed no significant differences
mong the groups, thereby revealing that the establishment
f IRS has no association with NO production in the liver
arenchyma.
With respect to lipid peroxidation in the reperfused liver,
o significant differences were detected In MDA concen-
rations among the investigated livers. This observation
ontrasts with suggestions by other authors16,17 that the
extent of IR correlates with tissue MDA content. As well as
our own rat studies.18
All of the above-mentioned results indicated that the
mechanism of IRS establishment is systemic, only being
“triggered” by some factor driven from the parenchyma.
Therefore, the systemic response is probably related to the
NO/GMPc (cyclic guanosine monophosphate) pathway, as
judged from the positive hemodynamic response to MB.
The ischemia period (60 minutes) used in the present
study was sufficient to produce circulatory shock in animals,
evidenced by the significant increase in lactate concentra-
tions and the difference in arterial and venous blood oxygen
saturations among the IR versus the control group. Treat-
ment with MB (R-MB group) reversed the increase in
circulatory shock parameters, which returned to values
similar to those detected in controls. However, a different
situation was observed when MB was used prophylactically
Fig 8. (A) Photomicrograph of the overview of the parenchyma
of an animal from the IR group presenting cell necrosis (¡)
(Giemsa; original magnification 100. (B) Detail showing diffuse
nfiltrates (¡) in 1 animal in to IR group Giemsa; originalagnification 400).
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3650 ROSIQUE, ROSIQUE, ROSIQUE ET AL(MB-R group). These data are consistent with other find-
ings of the present investigation: they provide one more
indication that MB becomes effective after some “trigger-
ing” factor is released into the bloodstream following
systemic circulatory shock. This fact was not evaluated in
the clinical study of Koelzow et al, who assessed only the
prophylactic use of MB.
Our histological findings showed that MB attenuated the
inflammatory response due to IR injury as measured by the
number of neutrophils at the hepatic lobe and near the portal
space. They were larger than those observed among groups
without IR. This observation was consistent with the hypoth-
esis that MB confers protection to intrahepatic endothelial
function. Extrapolated to the entire body, this hypothesis
supports the improved vascular response, evidenced by the
best MAP achieved on MB administration.
Maybe MB, one of the oldest drugs and the precursor of
antibiotics, chemotherapy agents, diuretics, and neurolep-
tics, has found a clinical use exceeding the principle “from
laboratory to clinical practice.” Its medical use is the
reverse of this principle, i.e., there has been an inversion of
the above-mentioned principle; MB use is now on its way
“from clinical practice to the laboratory,” which has been
the major motivation for the present research.
A treatment protocol for MB does not exist. The dose
used to treat methemoglobinemia (2 mg/kg intravenous
[IV] bolus) is generally applied. Because MB plasma levels
decrease sharply in the first 40 minutes, it is logical to
maintain the same dose as a continuous infusion in the
hours following IV bolus administration. There are per-
sonal reports on the use of up to 10 mg/kg MB without side
Fig 9. (A) Photomicrograph sho-
wing neutrophils within the intersti-
tial vessels (¡) and some small
epatocytes containing cytoplas-
ic vacuoles (*) observed in the
B-R group. (B) Intravascular neu-
trophils (¡) in an animal from the
R-MB group (Giemsa; original
magnification 400). (C) Average
number of neutrophils in a hepatic
lobe. (D) Average number of neu-
trophils near portal space. *The av-
erage number of neutrophils was
greater in IR, R-MB, and MB-R
compared with SHAM and MB
groups, which was statistically sig-
nificant (P  .0016; One-way
ANOVA test) between these 3
groups when compared with ani-
mals from MB and SHAM groups:
SHAM  IR (P  .01); SHAM 
R-MB and SHAM  MB-R (P 
.05); MB  IR (P  .01); MB 
R-MB and MB  MB-R (P  .05).effects.19In conclusion, MB improved the vital signs and promoted
lactate and oxygen extraction, leading to better survival
during reperfusion. However, the duration of this effect was
longer where we used MB treatment rather than prophy-
laxis. On the basis of the biochemical markers, we may
hypotherize that GC blockade by MB does not protect the
liver, strongly suggesting that the hemodynamic improve-
ment in IRS was not based on liver integrity but possibly on
a systemic vasoplegic endothelial dysfunction. In the pres-
ent research ischemia was induced only by clamping the
hepatic artery; it is well known that in this condition
75%–80% of the liver remains perfused through the portal
vein. This explains the fact that normal values were ob-
tained for the AST and ALT and reinforces the idea that
hemodynamic instability occurs irrespective of liver injury.
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